基于人群的英国生物银行研究中严重早发性肥胖基因罕见编码变异的影响
本研究分析英国生物银行419581名参与者的全外显子组序列数据,评估9个已知严重早发性肥胖基因的杂合变异对成年BMI和回忆性儿童期肥胖的影响,发现MC4R、PCSK1和POMC罕见LoF变异携带者成年BMI较高,效应量为0.5至2.5 kg/m2,且与BMI多基因风险评分无显著交互作用。
要点
- 在实验证实的LoF变异中(排除MC4R),3个常染色体隐性基因和3个常染色体显性基因的携带者肥胖外显率为8%至29%(中位数23%),与非携带者(24%)无显著差异(所有P > .05)。
- 生物信息学预测的罕见LoF变异基因负荷检验显示,MC4R、PCSK1和POMC杂合变异携带与成年BMI较高相关(效应量0.5至2.5 kg/m2,所有P < .003)。
- 罕见变异携带与BMI常见变异多基因风险评分之间无显著交互作用。
核心结论
- 本研究提供了已知肥胖基因变异外显率的人群特异性报告,并证实MC4R、POMC和PCSK1杂合罕见变异效应。
- 研究强调基于人群的研究在支持变异分类方面的效用。
研究设计与样本
- 基于英国生物银行(UKBB)419581名参与者的全外显子组序列数据,识别9个既往报道基因中实验证实为功能丧失(LoF)或生物信息学预测为罕见(次要等位基因频率<0.1%)LoF的编码变异杂合携带者。
- 评估变异水平和基因水平的肥胖人群外显率及与成年BMI和回忆性儿童期肥胖的关联,并检验罕见变异携带与BMI多基因评分之间的统计交互作用。
主要发现
- 考虑实验证实的LoF变异(排除MC4R),在3个常染色体隐性基因(POMC、PCSK1、LEPR)和3个常染色体显性基因(SH2B1、SIM1、KSR2)中鉴定出22个杂合变异和2个纯合变异,每个变异在UKBB中至少有10名携带者。
- 携带者中肥胖外显率范围为8%至29%(中位数23%),与非携带者(24%)均无显著差异(所有P > .05)。
- 对于生物信息学预测的罕见LoF变异,基于基因的负荷检验显示MC4R、PCSK1和POMC杂合变异携带与成年BMI较高相关(效应量范围为0.5至2.5 kg/m2,所有P < .003),与BMI常见变异多基因风险无显著交互效应。
关键数值与推荐
- 实验证实的LoF变异(排除MC4R)携带者肥胖外显率为8%至29%(中位数23%),非携带者为24%,所有P > .05。
- 生物信息学预测的罕见LoF变异中,MC4R、PCSK1和POMC杂合携带与成年BMI升高相关,效应量0.5至2.5 kg/m2,所有P < .003。
- 罕见变异携带与BMI多基因风险评分无显著交互作用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Clinical case-based studies have identified rare pathogenic variants in several genes as causes of severe early-onset obesity, but their penetrance and interaction with polygenic susceptibility in the general population remain unclear. OBJECTIVE: We analyzed the United Kingdom Biobank (UKBB) whole-exome sequence data to assess the effects of heterozygous variants in 9 previously reported genes on adult body mass index (BMI) and recalled childhood adiposity. METHODS: Among 419 581 UKBB participants, we identified heterozygous carriers of coding variants that were (1) experimentally characterized as loss of function (LoF), or (2) bioinformatically predicted as rare (minor allele frequency <0.1%) LoF. We assessed variant-level and gene-level population penetrance of obesity and associations with adult BMI and recalled childhood adiposity, and tested the statistical interaction between rare variant carriage and a BMI polygenic score. RESULTS: Considering experimentally characterized LoF variants (excluding MC4R), we identified 22 heterozygous and 2 homozygous variants in 3 autosomal recessive genes (POMC, PCSK1, LEPR), and 3 autosomal dominant genes (SH2B1, SIM1, KSR2) with at least 10 carriers in the UKBB. Obesity penetrance among carriers ranged from 8% to 29% (median 23%), and none was significantly different from noncarriers (24%, all P > .05). For bioinformatically predicted rare LoF variants, gene-based burden tests showed that carriage of heterozygous variants in MC4R, PCSK1, and POMC was associated with higher adult BMI (effect sizes ranged from 0.5 to 2.5 kg/m2, all P < .003), with no significant interaction effects with common variant polygenic risk of BMI. CONCLUSION: This study provides the population-specific report of variant penetrance of known obesity genes and confirmed the heterozygous rare variant effects in MC4R, POMC, and PCSK1. We also underscore the utility of population-based studies in supporting variant classifications.
引用
- Jia RY, Lockhart S, Lam BYH, et al. Effects of Rare Coding Variants in Severe Early-Onset Obesity Genes in the Population-Based UK Biobank Study. J Clin Endocrinol Metab. 2025. PMID: 40036808. doi:10.1210/clinem/dgaf132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。